| abstract |
The present invention relates to general formula (I) [Chemical 1] Wherein the substituents A, B, D, E, R 1 and R 2 are as defined in the specification, further physiologically acceptable salts thereof, processes for preparing said compounds and drugs Concerning its use as. Said compounds are kinase inhibitors, in particular inhibitors of the kinase GSK-3β (glycogen synthase kinase-3β). |